Yonsei Med J.  2013 May;54(3):560-566. 10.3349/ymj.2013.54.3.560.

Tools to Detect Influenza Virus

• Kim DK
• Poudel B

• KMID: 1727864
• DOI: http://doi.org/10.3349/ymj.2013.54.3.560

Abstract

In 2009, pandemic influenza A (H1N1) virus (H1N1 09) started to spread quickly in many countries. It causes respiratory infection with signs and symptoms of common infectious agents. Thus, clinicians sometimes may miss the H1N1 patient. Clinical laboratory tests are important for the diagnosis of the H1N1 infection. There are several tests available, however, the rapid test and direct fluorescence antigen test are unable to rule out the influenza virus infection and viral culture test is time consuming. Therefore, nucleic acid amplification techniques based on reverse transcription polymerase chain reaction assays are regarded as a specific diagnosis to confirm the influenza virus infection. Although the nucleic acid-based techniques are highly sensitive and specific, the high mutation rate of the influenza RNA-dependent RNA polymerase could limit the utility of the techniques. In addition, their use depends on the availability, cost and throughput of the diagnostic techniques. To overcome these drawbacks, evaluation and development of the techniques should be continued. This review provides an overview of various techniques for specific diagnosis of influenza infection.

Keyword

Influenza virus; H1N1; RT-PCR; laboratory diagnosis

MeSH Terms

Disease Outbreaks/prevention & control
Drug Resistance, Viral
Fluorescent Antibody Technique, Direct/methods
Humans
Influenza A Virus, H1N1 Subtype/drug effects/*genetics
Influenza, Human/*diagnosis/drug therapy
Polymerase Chain Reaction/methods
Sensitivity and Specificity
Time Factors

Reference

1. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009. 360:2605–2615.

2. Jeon EJ, Kim KH, Min KH. Acute eosinophilic pneumonia associated with 2009 influenza A (H1N1). Thorax. 2010. 65:268–270.

3. Monto AS, Kioumehr F. The Tecumseh Study of Respiratory Illness. IX. Occurence of influenza in the community, 1966--1971. Am J Epidemiol. 1975. 102:553–563.

4. Flasche S, Hens N, Boëlle PY, Mossong J, van Ballegooijen WM, Nunes B, et al. Different transmission patterns in the early stages of the influenza A(H1N1)v pandemic: a comparative analysis of 12 European countries. Epidemics. 2011. 3:125–133.

5. Wright PF, Neumann G, Kawaoka Y. Fields BN, Knipe DM, Howley PM, editors. Orthomyxoviruses. Fields' virology. 2007. 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins;1719–1721.

6. World Health Organization. Pandemic (H1N1) 2009-update 100. 2010. Available at: http://www.who.int/csr/don/2010_05_14/en/index.html.

7. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992. 56:152–179.

8. Caley P, Becker NG, Philp DJ. The waiting time for inter-country spread of pandemic influenza. PLoS One. 2007. 2:e143.

9. Cox NJ, Subbarao K. Influenza. Lancet. 1999. 354:1277–1282.

10. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010. 59:1–62.

11. Centres for Disease Control and Prevention (CDC). FluView: a weekly influenza surveillance report prepared by the influenza division. Available at: http://www.cdc.gov/flu/weekly/pdf/External_F1119.pdf.

12. Renaud C, Kuypers J, Aspesberro F, Rosenfeld M, Englund JA. Emergence of oseltamivir-resistant pandemic H1N1 in an immunocompetent child with severe status asthmaticus. J Asthma. 2011. 48:572–575.

13. Zhou J, Zou L, Zhang X, Liao J, Ni H, Hou N, et al. Adamantane- and oseltamivir-resistant seasonal A (H1N1) and pandemic A (H1N1) 2009 influenza viruses in Guangdong, China, during 2008 and 2009. J Clin Microbiol. 2011. 49:2651–2655.

14. Centers for Disease Control and Prevention (CDC). Role of Laboratory Diagnosis of Influenza. Available at: http://www.cdc.gov/flu/professionals/diagnosis/labrole.htm.

15. Influenza tests. Lab Tests Online. Available at: http://labtestsonline.org/understanding/analytes/flu/tab/sample.

16. Ward CL, Dempsey MH, Ring CJ, Kempson RE, Zhang L, Gor D, et al. Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement. J Clin Virol. 2004. 29:179–188.

17. Chen MI, Barr IG, Koh GC, Lee VJ, Lee CP, Shaw R, et al. Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study. PLoS One. 2010. 5:e12474.

18. Allwinn R, Geiler J, Berger A, Cinatl J, Doerr HW. Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med Microbiol Immunol. 2010. 199:117–121.

19. Centres for Disease Control and Prevention (CDC). Seasonal Influenza (Flu). Guidance for Clinicians on the Use of Rapid Influenza Diagnostic Tests. Available from URL: http://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm.

20. Treanor JJ. Mandell GL, Bennett JE, Dolin R, editors. Influenza virus. Principles and Practice of Infectious Disease. 2005. 2nd ed. Philadelphia, PA: Churchill Livingstone;2060.

21. López Roa P, Catalán P, Giannella M, García de Viedma D, Sandonis V, Bouza E. Comparison of real-time RT-PCR, shell vial culture, and conventional cell culture for the detection of the pandemic influenza A (H1N1) in hospitalized patients. Diagn Microbiol Infect Dis. 2011. 69:428–431.

22. Mahony JB. Detection of respiratory viruses by molecular methods. Clin Microbiol Rev. 2008. 21:716–747.

23. Zhirnov OP, Ikizler MR, Wright PF. Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases. J Virol. 2002. 76:8682–8689.

24. Operario DJ, Moser MJ, St George K. Highly sensitive and quantitative detection of the H274Y oseltamivir resistance mutation in seasonal A/H1N1 influenza virus. J Clin Microbiol. 2010. 48:3517–3524.

25. Matthey S, Nicholson D, Ruhs S, Alden B, Knock M, Schultz K, et al. Rapid detection of respiratory viruses by shell vial culture and direct staining by using pooled and individual monoclonal antibodies. J Clin Microbiol. 1992. 30:540–544.

26. Microlab. Performance Evaluation of R-Mix™, R-MixToo™ & PLC for the Detection of Respiratory Viruses. Available at: http://www.microgenbioproducts.com/pdf/Microlab%20Newsletters/MLAB_021.pdf.

27. Higgins AD, Shaw CJ, Johnson JG, Navarro A, Chapman NA, Ewers SD, et al. Monoclonal antibody kit for identification of the novel 2009 H1N1 influenza A virus. J Clin Microbiol. 2010. 48:2677–2682.

28. Centers for Disease Control and Prevention (CDC). Seasonal Influenza (Flu). Rapid Diagnostic Testing for Influenza. Available at: http://www.cdc.gov/flu/professionals/diagnosis/rapidlab.htm.

29. Lucas PM, Morgan OW, Gibbons TF, Guerrero AC, Maupin GM, Butler JL, et al. Diagnosis of 2009 pandemic influenza A (pH1N1) and seasonal influenza using rapid influenza antigen tests, San Antonio, Texas, April-June 2009. Clin Infect Dis. 2011. 52:Suppl 1. S116–S122.

30. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011. 377:1264–1275.

31. Landry ML. Diagnostic tests for influenza infection. Curr Opin Pediatr. 2011. 23:91–97.

32. Faix DJ, Sherman SS, Waterman SH. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009. 361:728–729.

33. Vasoo S, Stevens J, Singh K. Rapid antigen tests for diagnosis of pandemic (Swine) influenza A/H1N1. Clin Infect Dis. 2009. 49:1090–1093.

34. Al Johani SM, Al Balawi M, Al Alwan B, Al Hefdhi R, Hajeer A. Validity of two rapid point of care influenza tests and direct fluorecence assay in comparison of real time PCR for swine of origin Influenza virus. J Infect Public Health. 2011. 4:7–11.

35. Tsao KC, Kuo YB, Huang CG, Chau SW, Chan EC. Performance of rapid-test kits for the detection of the pandemic influenza A/H1N1 virus. J Virol Methods. 2011. 173:387–389.

36. Choi WS, Noh JY, Huh JY, Kee SY, Jeong HW, Lee J, et al. The clinical usefulness of the SD Bioline Influenza Antigen Test® for detecting the 2009 influenza A (H1N1) virus. Yonsei Med J. 2011. 52:683–685.

37. Heinonen S, Silvennoinen H, Lehtinen P, Vainionpää R, Heikkinen T. Feasibility of diagnosing influenza within 24 hours of symptom onset in children 1-3 years of age. Eur J Clin Microbiol Infect Dis. 2011. 30:387–392.

38. Stripeli F, Sakkou Z, Papadopoulos N, Georgiou V, Gratsia P, Christodoulou I, et al. Performance of rapid influenza testing in hospitalized children. Eur J Clin Microbiol Infect Dis. 2010. 29:683–688.

39. Sadeghi CD, Aebi C, Gorgievski-Hrisoho M, Mühlemann K, Barbani MT. Twelve years' detection of respiratory viruses by immunofluorescence in hospitalised children: impact of the introduction of a new respiratory picornavirus assay. BMC Infect Dis. 2011. 11:41.

40. Centers for Disease Control and Prevention (CDC). Interim Recommendations for Clinical Use of Influenza Diagnostic Tests During the 2009-10 Influenza Season. Available at: http://www.cdc.gov/h1n1flu/guidance/diagnostic_tests.htm.

41. Pollock NR, Duong S, Cheng A, Han LL, Smole S, Kirby JE. Ruling out novel H1N1 influenza virus infection with direct fluorescent antigen testing. Clin Infect Dis. 2009. 49:e66–e68.

42. Lee JH, Shin SR, Cho JH. Evaluation of direct immunofluorescence test with PCR for detection of novel influenza A (H1N1) virus during 2009 pandemic. Yonsei Med J. 2011. 52:680–682.

43. Pianciola L, González G, Mazzeo M, Navello M, Quidel N, Bulgheroni MF. [Direct immunofluorescence assay performance in diagnosis of the Influenza A(H1N1) virus]. Rev Panam Salud Publica. 2010. 27:452–454.

44. Ganzenmueller T, Kluba J, Hilfrich B, Puppe W, Verhagen W, Heim A, et al. Comparison of the performance of direct fluorescent antibody staining, a point-of-care rapid antigen test and virus isolation with that of RT-PCR for the detection of novel 2009 influenza A (H1N1) virus in respiratory specimens. J Med Microbiol. 2010. 59(Pt 6):713–717.

45. Freymuth F, Vabret A, Brouard J, Toutain F, Verdon R, Petitjean J, et al. Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol. 1999. 13:131–139.

46. Vabret A, Sapin G, Lezin B, Mosnier A, Cohen J, Burnouf L, et al. Comparison of three non-nested RT-PCR for the detection of influenza A viruses. J Clin Virol. 2000. 17:167–175.

47. Wang R, Taubenberger JK. Methods for molecular surveillance of influenza. Expert Rev Anti Infect Ther. 2010. 8:517–527.

48. Zhang WD, Evans DH. Detection and identification of human influenza viruses by the polymerase chain reaction. J Virol Methods. 1991. 33:165–189.

49. Ellis JS, Fleming DM, Zambon MC. Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996. J Clin Microbiol. 1997. 35:2076–2082.

50. Chen KF, Blyn L, Rothman RE, Ramachandran P, Valsamakis A, Ecker D, et al. Reverse transcription polymerase chain reaction and electrospray ionization mass spectrometry for identifying acute viral upper respiratory tract infections. Diagn Microbiol Infect Dis. 2011. 69:179–186.

51. Carr MJ, Gunson R, Maclean A, Coughlan S, Fitzgerald M, Scully M, et al. Development of a real-time RT-PCR for the detection of swine-lineage influenza A (H1N1) virus infections. J Clin Virol. 2009. 45:196–199.

52. Ge Y, Cui L, Qi X, Shan J, Shan Y, Qi Y, et al. Detection of novel swine origin influenza A virus (H1N1) by real-time nucleic acid sequence-based amplification. J Virol Methods. 2010. 163:495–497.

53. Lau LT, Feng XY, Lam TY, Hui HK, Yu AC. Development of multiplex nucleic acid sequence-based amplification for detection of human respiratory tract viruses. J Virol Methods. 2010. 168:251–254.

54. Nanosphere. Verigene® Respiratory Virus Plus Nucleic Acid Test (RV+). Available at: http://www.nanosphere.us/VerigeneRespiratoryVirusPlusNucleicAcidTestRV_5320.aspx.

55. Cepheid. Cepheid Announces Accelerated Development of Flu A Panel Test. Available at: http://www.cepheid.com/company/news-events/press-releases/index.cfm?releaseID=1329451.

56. Bao JR, Huard TK, Piscitelli AE, Tummala PR, Aleemi VE, Coon SL, et al. Reverse-transcription polymerase chain reaction/pyrosequencing to characterize neuraminidase H275 residue of influenza A 2009 H1N1 virus for rapid and specific detection of the viral oseltamivir resistance marker in a clinical laboratory. Diagn Microbiol Infect Dis. 2011. 71:396–402.

57. Hurt AC, Chotpitayasunondh T, Cox NJ, Daniels R, Fry AM, Gubareva LV, et al. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis. 2012. 12:240–248.

58. Suzuki Y, Saito R, Sato I, Zaraket H, Nishikawa M, Tamura T, et al. Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an His275Tyr genotyping assay using the cycling probe method. J Clin Microbiol. 2011. 49:125–130.